BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33717248)

  • 1. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
    Zhong P; Shu R; Wu H; Liu Z; Shen X; Hu Y
    Exp Ther Med; 2021 Apr; 21(4):305. PubMed ID: 33717248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implication of Keratin-15 Quantification for Renal Cell Carcinoma Management: Its Dysregulation and Association with Clinicopathologic Characteristics and Prognostication.
    Zhang W; Chen P; Li Z; Zhang R; Zhang J
    Tohoku J Exp Med; 2023 May; 260(2):99-107. PubMed ID: 36858509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor keratin 15 expression links with less extent of invasion and better prognosis in papillary thyroid cancer patients receiving tumor resection.
    Yang X; Liu Z; Wang X; Han Z; Zhang C; Guo L
    Ir J Med Sci; 2024 Feb; 193(1):9-15. PubMed ID: 37243844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
    Lu J; Hu F; Zhou Y
    Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
    Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
    Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression landscape of FOXP3 and its prognostic value in breast cancer.
    Li J; Zhang X; Liu B; Shi C; Ma X; Ren S; Zhao X; Liu Y
    Ann Transl Med; 2022 Jul; 10(14):801. PubMed ID: 35965804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic analyses of genes associated with anoikis in breast cancer.
    Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
    PeerJ; 2023; 11():e15475. PubMed ID: 37842046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer.
    Zhao D; Li W; Wang Y; Zhang G; Bai X; Yu H
    Transl Cancer Res; 2023 Dec; 12(12):3503-3521. PubMed ID: 38197075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
    Wang Z; Wang F
    Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of
    Liu X; Cui Q; Qin N
    Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.